• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect or residual confounding?

作者信息

Dongelmans Edo J, Sonneveld Milan J, Janssen Harry L A

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.

出版信息

Hepatology. 2024 Mar 1;79(3):E95-E96. doi: 10.1097/HEP.0000000000000639. Epub 2023 Oct 20.

DOI:10.1097/HEP.0000000000000639
PMID:37862458
Abstract
摘要

相似文献

1
Letter to the Editor: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect or residual confounding?致编辑的信：乙型肝炎肝硬化患者停止治疗的益处，是真实效果还是残余混杂因素？
Hepatology. 2024 Mar 1;79(3):E95-E96. doi: 10.1097/HEP.0000000000000639. Epub 2023 Oct 20.
2
Reply: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect, or residual confounding?回复：乙型肝炎肝硬化患者停止治疗的益处、真实效果还是残余混杂因素？
Hepatology. 2024 Mar 1;79(3):E97-E98. doi: 10.1097/HEP.0000000000000641. Epub 2023 Oct 20.
3
Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.
Hepatology. 2024 Apr 1;79(4):E107-E108. doi: 10.1097/HEP.0000000000000654. Epub 2023 Oct 31.
4
Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma.抗病毒治疗、乙肝表面抗原血清清除及乙肝相关肝细胞癌的晚期复发
J Hepatol. 2022 Nov;77(5):1471-1472. doi: 10.1016/j.jhep.2022.07.005. Epub 2022 Jul 19.
5
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B.定量乙型肝炎表面抗原，慢性乙型肝炎功能性治愈的可靠生物标志物。
Gut Liver. 2023 Mar 15;17(2):179-180. doi: 10.5009/gnl230070.
6
Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring.利用乙型肝炎核心相关抗原检测优化治疗后监测。
Clin Mol Hepatol. 2024 Apr;30(2):293-296. doi: 10.3350/cmh.2024.0101. Epub 2024 Feb 19.
7
KASL clinical practice guidelines for management of chronic hepatitis B.《慢性乙型肝炎管理的KASL临床实践指南》
Clin Mol Hepatol. 2019 Jun;25(2):93-159. doi: 10.3350/cmh.2019.1002. Epub 2019 Jun 12.
8
[Research progress of biomarkers of hepatitis B virus and clinical significance].[乙型肝炎病毒生物标志物的研究进展及临床意义]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023 Dec 25;40(6):1242-1248. doi: 10.7507/1001-5515.202309041.
9
Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues.
Aliment Pharmacol Ther. 2023 Mar;57(5):587-588. doi: 10.1111/apt.17329.
10
[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].恩替卡韦对乙型肝炎病毒相关性肝硬化患者的抗病毒作用
Zhonghua Gan Zang Bing Za Zhi. 2010 Feb;18(2):109-12. doi: 10.3760/cma.j.issn.1007-3418.2010.02.008.

引用本文的文献

1
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure.慢性乙型肝炎中继续抗病毒治疗与停止治疗的临床影响：一项对乙肝治愈有启示的建模研究
J Viral Hepat. 2025 Oct;32(10):e70079. doi: 10.1111/jvh.70079.
2
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0.慢性乙型肝炎功能性治愈的治疗导航更新：专家共识2.0
Clin Mol Hepatol. 2025 Feb;31(Suppl):S134-S164. doi: 10.3350/cmh.2024.0780. Epub 2025 Jan 22.